Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The loophole is Section 503B of the Federal Food, Drug, and Cosmetic Act, which enables compounding facilities to produce knockoff versions of drugs that are in shortage
It will be essential for voluntary licensing to enable access in low- and middle-income countries using generic formulations
Serious but rare adverse effects include pancreatitis, hypoglycaemia when combined with insulin or sulfonylureas, and gallbladder problems
5-6
US$ 24.38
US$ 27.66
US$ 26.76
US$ 22.02
US$ 28.80
US$ 25.23
US$ 20.05
US$ 22.80
US$ 24.62
US$ 28.09
US$ 21.95
US$ 21.73
US$ 21.03
